A detailed history of High Falls Advisors, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, High Falls Advisors, Inc holds 560 shares of LLY stock, worth $421,909. This represents 0.12% of its overall portfolio holdings.

Number of Shares
560
Previous 526 6.46%
Holding current value
$421,909
Previous $476,000 4.2%
% of portfolio
0.12%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $26,252 - $32,640
34 Added 6.46%
560 $496,000
Q2 2024

Aug 15, 2024

BUY
$724.87 - $909.04 $25,370 - $31,816
35 Added 7.13%
526 $476,000
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $290,770 - $389,009
491 New
491 $381,000
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $362,905 - $469,415
-2,010 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $330,283 - $427,567
2,010 New
2,010 $376,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track High Falls Advisors, Inc Portfolio

Follow High Falls Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Falls Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on High Falls Advisors, Inc with notifications on news.